SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-009062
Filing Date
2024-03-25
Accepted
2024-03-25 19:09:14
Documents
1
Period of Report
2024-03-25

Document Format Files

Seq Description Document Type Size
1 form4-03252024_110307.html 4  
1 form4-03252024_110307.xml 4 3149
  Complete submission text file 0001415889-24-009062.txt   4714
Mailing Address C/O ENTASIS THERAPEUTICS HOLDINGS INC. 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address
Berger Heather A. (Reporting) CIK: 0001751873 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40288 | Film No.: 24780574

Mailing Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011
Business Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011 858-293-4900
Design Therapeutics, Inc. (Issuer) CIK: 0001807120 (see all company filings)

IRS No.: 823929248 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)